152 related articles for article (PubMed ID: 6701182)
1. A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine.
Cioli V; Corradino C; Piccinelli D; Rocchi MG; Valeri P
Pharmacol Res Commun; 1984 Jan; 16(1):85-100. PubMed ID: 6701182
[TBL] [Abstract][Full Text] [Related]
2. 1-(m-Chlorophenyl)piperazine induces depressogenic-like behaviour in rodents by stimulating the neuronal 5-HT(2A) receptors: proposal of a modified rodent antidepressant assay.
Rajkumar R; Pandey DK; Mahesh R; Radha R
Eur J Pharmacol; 2009 Apr; 608(1-3):32-41. PubMed ID: 19269287
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
Lucki I; Ward HR; Frazer A
J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329
[TBL] [Abstract][Full Text] [Related]
4. Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent Trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus.
Malomvölgyi B; Tóthfalusi L; Tekes K; Magyar K
Acta Physiol Hung; 1991; 78(3):201-9. PubMed ID: 1814162
[TBL] [Abstract][Full Text] [Related]
5. Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity.
Raffa RB; Shank RP; Vaught JL
Psychopharmacology (Berl); 1992; 108(3):320-6. PubMed ID: 1387963
[TBL] [Abstract][Full Text] [Related]
6. Blockade of conditioned avoidance responding by trazodone, etoperidone, and MCPP.
Martin GE; Mathiasen JR; Kesslick JM
Psychopharmacology (Berl); 1989; 99(1):94-7. PubMed ID: 2506609
[TBL] [Abstract][Full Text] [Related]
7. On the central antiserotonin action of trazodone.
Baran L; Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1979; 31(1):25-33. PubMed ID: 482164
[TBL] [Abstract][Full Text] [Related]
8. The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system.
Przegaliński E; Lewandowska A
J Neural Transm; 1979; 46(4):303-12. PubMed ID: 529000
[TBL] [Abstract][Full Text] [Related]
9. Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone.
Melzacka M; Rurak A; Vetulani J
Pol J Pharmacol Pharm; 1980; 32(4):551-6. PubMed ID: 7255270
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological action of zotepine and other antipsychotics on central 5-hydroxytryptamine receptor subtypes.
Czyrak A; Skuza G; Rogóz Z; Frankiewicz T; Maj J
Arzneimittelforschung; 1994 Feb; 44(2):113-8. PubMed ID: 7511901
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological investigations on etoperidone, a new psychotropic agent.
Lisciani R; Baldini A; de Feo G; Silvestrini B
Arzneimittelforschung; 1978; 28(3):417-23. PubMed ID: 580751
[No Abstract] [Full Text] [Related]
12. Pharmacological evaluation of delta2, 1,2,4-triazolin-5-one [1,3(4-m-chlorophenyl-1-piperazinyl)-propyl]-3,4-diethyl-hydrochloride (Etoperidone), a new potential antidepressant drug.
Ramacci MT; Ghirardi O; Maccari F; Pacifici L; Sale P
Arzneimittelforschung; 1979; 29(2):294-307. PubMed ID: 582144
[No Abstract] [Full Text] [Related]
13. Effect of dosage and route of administration of trazodone on cerebral concentration of 1-m-chlorophenylpiperazine in rats. Kinetics of trazodone biotransformation in rats.
Rurak A; Melzacka M
Pol J Pharmacol Pharm; 1983; 35(3):241-7. PubMed ID: 6622303
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and pharmacological study of butyric derivative in piperazinic series: 4-butanoyl-1-(3-chlorophenyl) piperazine].
Pieri F; Sefraoui H; Arnould-Guérin ML; Kirkiacharian S; Cheav SL
Ann Pharm Fr; 1995; 53(3):119-23. PubMed ID: 7677392
[No Abstract] [Full Text] [Related]
15. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.
Odagaki Y; Toyoshima R; Yamauchi T
J Psychopharmacol; 2005 May; 19(3):235-41. PubMed ID: 15888508
[TBL] [Abstract][Full Text] [Related]
16. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
Hancock AA; Buckner SA; Giardina WJ; Brune ME; Lee JY; Morse PA; Oheim KW; Stanisic DS; Warner RB; Kerkman DJ
J Pharmacol Exp Ther; 1995 Mar; 272(3):1160-9. PubMed ID: 7891328
[TBL] [Abstract][Full Text] [Related]
17. Effects of trazodone and m-chlorophenylpiperazine (m-CPP) on acute dependence in mice.
Valeri P; Pimpinella G; Troiani MP; Morrone LA; Romanelli L
Brain Res Bull; 1991 May; 26(5):799-802. PubMed ID: 1933399
[TBL] [Abstract][Full Text] [Related]
18. [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].
Duchene-Marullaz P; Rispat G; Perriere JP; Hache J; Labrid C
Therapie; 1971; 26(6):1203-9. PubMed ID: 4401719
[No Abstract] [Full Text] [Related]
19. Inhibitory effects of etoperidone on the spontaneous activity of brainstem neurones and their excitatory responses to some putative transmitters.
Janiri L; Salera P; Tempesta E
Arzneimittelforschung; 1986 Dec; 36(12):1721-6. PubMed ID: 2882758
[TBL] [Abstract][Full Text] [Related]
20. Effects of etoperidone on sympathetic and pituitary-adrenal responses to diverse stressors in humans.
Costa A; Martignoni E; Blandini F; Petraglia F; Genazzani AR; Nappi G
Clin Neuropharmacol; 1993 Apr; 16(2):127-38. PubMed ID: 8386590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
